Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/33299
Title: The impact of artificial sweeteners on bacterial physiology and the microbiome
Authors: Staber, C
Krawiel, D
McCarthy, RR
Issue Date: 13-Apr-2026
Publisher: Cell Press (Elsevier)
Citation: Staber, C., Krawiel, D. and McCarthy, R.R. (2026) 'The impact of artificial sweeteners on bacterial physiology and the microbiome', Trends in Microbiology, 34 (5), pp. 549–577. doi: 10.1016/j.tim.2026.01.010.
Abstract: Artificial sweeteners are non-nutritive compounds that have a profound sweetening effect with a negligible to zero calorific contribution. Global initiatives to reduce sugar consumption to tackle health conditions such as obesity have led to a significant increase in their consumption in recent decades. Artificial sweeteners have undergone extensive testing to determine whether their consumption could impact human health; however, their impact on the microbiome and microbial physiology has been comparatively overlooked. Recent work has demonstrated that artificial sweeteners (e.g., Ace-K, saccharin, and aspartame) can influence the oral and gut microbiome and that they can significantly affect bacterial behavior and growth. In this review, we will contextualize these findings and explore their relevance to human artificial sweetener consumption.
Description: Highlights: • Artificial sweeteners have been shown to impact the human gut microbiome to varying levels, with saccharin having the most pronounced effect, influencing the human glycemic response via gut microbiome dysbiosis. • At environmentally relevant concentrations, a range of artificial sweeteners have been shown to impact bacterial conjugation and natural transformation. • Several artificial sweeteners have been shown to inhibit bacterial growth, including the growth of multidrug-resistant pathogens. • Certain artificial sweeteners, such as Ace-K and saccharin, have also shown antivirulence potential by inhibiting biofilm formation and increasing antibiotic susceptibility, highlighting their therapeutic potential.
Supplemental information is available online at: https://www.cell.com/cms/10.1016/j.tim.2026.01.010/attachment/8d35106f-6e32-4b22-9518-3f89debfe7a5/mmc1.docx (Document (189.36 KB).
URI: https://bura.brunel.ac.uk/handle/2438/33299
DOI: https://doi.org/10.1016/j.tim.2026.01.010
ISSN: 0966-842X
Other Identifiers: ORCiD: Ronan R. McCarthy https://orcid.org/0000-0002-7480-6352
Appears in Collections:Department of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2026 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).773 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.